2026 NPPES data Specialist NPI 1790869352 MD
Verify on CMS →

MARK SILVER, MD

Specialist in MOUNTLAKE TERRACE, Washington. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
4K
Medicare Part D claims · 244 beneficiaries · Specialist avg: 1K
Generic prescribing
57%
generic claims · 43% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$644.69
20 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

MARK SILVER, MD filed 3,673 Medicare Part D claims in 2023 as a Specialist in MOUNTLAKE TERRACE, Washington, prescribing 57% generic.

4K
Part D claims, 2023
57%
generic prescribing
$644.69
industry payments (Sunshine Act)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

MARK SILVER, MD's Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2023 — across all CMS prescribers nationally

3,673 Top 9% higher than 91% of 1,370,886 prescribers

0–200: 670,926 prescribers (49%). Below this entry. 200–400: 182,923 prescribers (13%). Below this entry. 400–600: 90,619 prescribers (7%). Below this entry. 600–800: 56,224 prescribers (4%). Below this entry. 800–1,000: 40,919 prescribers (3%). Below this entry. 1,000–1,200: 31,827 prescribers (2%). Below this entry. 1,200–1,400: 26,224 prescribers (2%). Below this entry. 1,400–1,600: 21,710 prescribers (2%). Below this entry. 1,600–1,800: 19,072 prescribers (1%). Below this entry. 1,800–2,000: 16,451 prescribers (1%). Below this entry. 2,000–2,200: 213,991 prescribers (16%). This entry sits in this band. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Medicare Part D Prescriber Public Use File · 2023

What does the federal data show about MARK SILVER, MD?

Quality data not reported

NPI registry status

Active

Issued 10/24/2006

NPI 1790869352

Primary specialty

Specialist

High-volume

69,658 US NPIs in this specialty

Medicare Part D claims

3,673 149% vs specialty avg

2023 prescription claims

Specialty avg: 1,474

Specialty distribution in Washington

How Specialist compares to other specialties among Washington providers

Washington providers

Specialist share within Washington

1. Specialist42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Specialist share within Washington

Specialty board-certification context

Estimated specialty board-certified rate — Specialist (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Specialist ABMS/AOA estimate

Est. board-certified rate (Specialist) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Specialist) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

MARK SILVER, MD appears in the CMS NPPES registry as a Specialist provider holding MD credentials at 6100 219TH ST SW STE 480, MOUNTLAKE TERRACE, WA, 98043, with a listed phone of (425) 774-5104. NPI 1790869352 was issued on 10/24/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what SILVER most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 3,673 prescription claims written by this provider, covering 244 Medicare beneficiaries and totaling roughly $1.7 million in drug spend, split 43% brand-name and 57% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Specialist is a high-volume specialty nationwide, with 69,658 enrolled providers across 55 states and an average of 1,474 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

6100 219TH ST SW STE 480
MOUNTLAKE TERRACE, WA 98043

Provider Details

NPI 1790869352
Specialty Specialist
Credentials MD
Gender Male
NPI Issued 10/24/2006

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for MARK SILVER, MD. Source: openpaymentsdata.cms.gov.

Total received

$645

Largest payer

Xeris Pharmaceuticals, Inc.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — Washington WMC 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~34K Washington medical licensees in 2023 — they are NOT specific to MARK SILVER, MD. To verify MARK SILVER, MD's current license status, search the WMC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

88
Total board actions, Washington 2023
Across 85 cases
2.59
Actions per 1,000 licensees
Washington statewide rate
probation
Most common action type
31 cases

WMC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Washington disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Above average

MARK SILVER, MD — brand share 43.0%
Specialty average (est.)

43% brand-name claims vs 57% generic, on 3,673 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

3,673
Total Claims
$1.7M
Total Drug Cost
244
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
8,674
Total Day Supply
257,577
Brand vs Generic
43% brand / 57% generic
Brand Drug Cost
$1.6M
Generic Drug Cost
$80K

Patient Demographics

Average Patient Age
73.1 years
Avg HCC Risk Score
1.42
Gender Split
49% female / 51% male
Age Distribution
<65: 15, 65-74: 126, 75-84: 85, 85+: 18

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What MARK SILVER, MD prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Rosuvastatin Calcium
407
Levoxyl
Levothyroxine Sodium
274
Metformin Hcl Er
Metformin Hcl
214
Ozempic
Semaglutide
131
Amlodipine Besylate
117
Jardiance
Empagliflozin
110
Synthroid
Levothyroxine Sodium
108
Tresiba Flextouch U-100
Insulin Degludec
105
Lisinopril
100
Ezetimibe
94

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Specialist Overview

How MARK SILVER, MD fits within the Specialist landscape nationally.

69,658
Specialist Providers in US
55
States with Specialist
1,474
Avg Claims per Provider

MARK SILVER, MD's 3,673 claims are above the specialty average of 1,474.

Nearby Specialist Providers in Washington

Other clinicians with the same primary specialty enrolled in Washington, drawn from the same CMS NPPES roster as SILVER.

Compare Specialist nationally: see state-by-state distribution →

Frequently Asked Questions

What is MARK SILVER, MD's specialty?
MARK SILVER, MD specializes in Specialist and practices in MOUNTLAKE TERRACE, Washington. Credentials: MD.
How much does MARK SILVER, MD prescribe under Medicare Part D?
In 2023, MARK SILVER, MD wrote 3,673 Medicare Part D claims totaling $1.7M in drug costs for 244 beneficiaries.
Where is MARK SILVER, MD located?
MARK SILVER, MD is located at 6100 219TH ST SW STE 480, MOUNTLAKE TERRACE, WA, 98043. Phone: (425) 774-5104.
What is MARK SILVER, MD's NPI number?
MARK SILVER, MD's National Provider Identifier (NPI) is 1790869352, issued on 10/24/2006.
Does MARK SILVER, MD prescribe more brand-name or generic drugs?
MARK SILVER, MD's prescribing is 43% brand-name and 57% generic drugs by claim count, with $1.6M in brand drug costs.
How many Specialist providers are there in the US?
There are 69,658 Specialist providers across 55 states in the US. The average Specialist provider writes 1,474 Medicare Part D claims per year.
What drugs does MARK SILVER, MD prescribe most often?
Based on 2023 Medicare Part D data, MARK SILVER, MD's most frequently prescribed drugs include Rosuvastatin Calcium, Levoxyl, Metformin Hcl Er. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does MARK SILVER, MD accept Medicare?
MARK SILVER, MD appears in CMS Medicare data with 3,673 Part D claims and 244 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify MARK SILVER, MD's credentials?
MARK SILVER, MD's NPI is 1790869352 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology